ReviewReviews in endocrine & metabolic disorders2011
Estrogen and thrombosis: controversies and common sense.
Review in Reviews in endocrine & metabolic disorders, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A nomogram clinical model for predicting preoperative lower limb venous thrombosis in knee ligament injuries: a retrospective study.Frontiers in medicine · 2025Article
- High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states.BMC neurology · 2024Article
- Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database.Drugs - real world outcomes · 2022Article
- Estrogen and estrogen receptors in kidney diseases.Renal failure · 2021Review
- Estrogen and thrombosis: A bench to bedside review.Thrombosis research · 2020Review
- Evaluation of activity of hypothalamo-pituitary-gonadal axis in postmenopausal women suffering from severe acute illness.The Indian journal of medical research · 2016Article
- The sexual dimorphism associated with pulmonary hypertension corresponds to a fibrotic phenotype.Pulmonary circulation · 2015Article
- Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke.Hormones and behavior · 2013Review
- Life-threatening complications of hormonal contraceptives: a case history.Case reports in obstetrics and gynecology · 2013Article
- Impact of Severity of Illness on the Function of the Hypothalamo-pituitary-gonadal Axis in Postmenopausal Women with Acute Severe Illness: Implications for Predicting Disease Outcome.Indian journal of endocrinology and metabolismArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soon after the introduction of hormonal oral contraceptive agents reports of thrombotic complications appeared. In the past several decades, large epidemiological studies helped defined these risks for both arterial and venous complications. Clinicians can assess a patient's risk of thrombosis by both composition of the agent and patients' personal risk factors. For women with bleeding disorders these prothrombotic changes can help decrease bleeding complications. There is now also abundant data on future management of patients with estrogen related thrombosis.
Indexed as
Identifiers
21559819What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.